Rempex Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REMPEX, and what generic alternatives to REMPEX drugs are available?
REMPEX has two approved drugs.
There are nine US patents protecting REMPEX drugs.
There are eighty-nine patent family members on REMPEX drugs in thirty-two countries and thirty supplementary protection certificates in fourteen countries.
Drugs and US Patents for Rempex
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 11,007,206 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 10,172,874 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rempex | MINOCIN | minocycline hydrochloride | INJECTABLE;INJECTION | 050444-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | 9,084,802 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 8,680,136 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Rempex Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 102970992 | ⤷ Try a Trial |
Denmark | 3412676 | ⤷ Try a Trial |
Mexico | 347919 | ⤷ Try a Trial |
Japan | 6602742 | ⤷ Try a Trial |
Hong Kong | 1180586 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Rempex Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2603514 | C201930023 | Spain | ⤷ Try a Trial | PRODUCT NAME: VABORBACTAM, Y/O UNA SAL Y/O UN HIDRATO DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/18/1334; DATE OF AUTHORISATION: 20181120; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/18/1334; DATE OF FIRST AUTHORISATION IN EEA: 20181120 |
2603514 | 2019/017 | Ireland | ⤷ Try a Trial | PRODUCT NAME: VABORBACTAM, AND/OR A SALT AND/OR HYDRATE THEREOF; AUTHORISATION NO/DATE: EU/1/18/1334 20181120 |
2603514 | 2019C/514 | Belgium | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CESSION |
3412676 | PA2020519 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120 |
3412676 | C20200018 00316 | Estonia | ⤷ Try a Trial | PRODUCT NAME: VABORBAKTAAM;REG NO/DATE: EU/1/18/1334 22.11.2018 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.